Skip to content
value.today

Bio-Path Holdings Inc.

Total raised
$16 M
7 rounds on record
Latest round
$4 M
Oct 2024
First round on record
May 2012
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Bio-Path Holdings Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2024$4 MNo. 7$2 to $10 million

Bio-Path Holdings Inc.: Raise no. 7, Oct 2024

Investors in this round

1 investor had bought by the notice of Oct 22, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$340,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Peter H. Nielsen · Executive Officer, Director
  • Aline P, Sherwood · Director
  • Douglas P, Morris · Director
  • Heath W. Cleaver · Director
  • Paul D. Aubert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co., LLC (CRD 375) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “H.C. Wainwright & Co., LLC received the above sales commission and warrants to purchase up to an aggregate of 344,828 shares of the Company's common stock, par value $0.001 per share at an exercise price equal to $1.0875 per share as compensation.”
  • On the amounts: “Includes the gross proceeds received in the offering.”

Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 22, 2024. Read the notice at the SEC.

equity, optionsSEC
Jun 2024$4 MNo. 6$2 to $10 million

Bio-Path Holdings Inc.: Raise no. 6, Jun 2024

Investors in this round

1 investor had bought by the notice of Jun 13, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$340,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Peter H. Nielsen · Executive Officer, Director
  • Aline P. Sherwood · Director
  • Douglas P. Morris · Director
  • Heath W. Cleaver · Director
  • Paul D. Aubert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co., LLC (CRD 375) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “H.C. Wainwright & Co., LLC received the above sales commission and the HCW Warrants as consideration.”
  • On the amounts: “Includes the gross proceeds received in the offering.”

Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 13, 2024. Read the notice at the SEC.

equity, optionsSEC
Apr 2024$1 MNo. 5Under $2 million

Bio-Path Holdings Inc.: Raise no. 5, Apr 2024

Investors in this round

3 investors had bought by the notice of Apr 26, 2024: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$102,796
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Peter H. Nielsen · Executive Officer, Director
  • Aline P. Sherwood · Director
  • Douglas P. Morris · Director
  • Heath W. Cleaver · Director
  • Paul D. Aubert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co., LLC (CRD 375) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “H.C. Wainwright & Co., LLC received the above sales commission and the HCW Warrants as consideration, in connection with a registered direct offering by the Issuer, which is not reported on this Form D.”
  • On the amounts: “"Includes warrants to purchase up to 375,000 shares of common stock and warrants to purchase up to 28,125 shares of common stock issued to H.C. Wainwright & Co., LLC (""HCW Warrants""), with an exercise price of $3.10 and $4.0313, respectively."”

Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 26, 2024. Read the notice at the SEC.

optionsSEC
Nov 2022$2 MNo. 4$2 to $10 million

Bio-Path Holdings Inc.: Raise no. 4, Nov 2022

Investors in this round

5 investors had bought by the notice of Nov 18, 2022: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$140,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Peter H. Nielsen · Executive Officer, Director
  • Aline D. Sherwood · Director
  • Douglas P. Morris · Director
  • Heath W. Cleaver · Director
  • Paul D. Aubert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • ROTH Capital Partners, LLC (CRD 15407) · Newport Beach, CaliforniaSold in all US states

Remarks in the notice

  • On fees: “ROTH Capital Partners, LLC received the above sales commission in connection with a concurrent registered direct offering by the Issuer, which is not reported on this Form D.”
  • On the amounts: “Includes warrants to purchase up to 800,000 shares of common stock issued to investors at an exercise price equal to $2.85 per share. As of the date hereof, no such warrants have been exercised.”

Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 18, 2022. Read the notice at the SEC.

optionsSEC
Mar 2019$1 MNo. 3Under $2 million

Bio-Path Holdings Inc.: Raise no. 3, Mar 2019

Investors in this round

4 investors had bought by the notice of Mar 18, 2019: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,295,001
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Peter H. Nielsen · Executive Officer, Director
  • Douglas P. Morris · Director
  • Heath W. Cleaver · Director
  • Mark P. Colonnese · Director
  • Paul D. Aubert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co., LLC (CRD 375) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “H.C. Wainwright & Co., LLC received the above sales commission and the HCW Warrants in connection with a registered direct offering by the Issuer, which is not reported on this Form D.”
  • On the amounts: “"Includes warrants to purchase up to 42,775 shares of common stock issued to H.C. Wainwright & Co., LLC (""HCW Warrants"") and all underlying shares thereof."”

Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 18, 2019. Read the notice at the SEC.

optionsSEC
Sep 2018$2 MNo. 2$2 to $10 million

Bio-Path Holdings Inc.: Raise no. 2, Sep 2018

Investors in this round

4 investors had bought by the notice of Oct 5, 2018: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$102,899
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Peter H. Nielsen · Executive Officer, Director
  • Douglas P. Morris · Director
  • Heath W. Cleaver · Director
  • Mark P. Colonnese · Director
  • Paul D. Aubert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co., LLC (CRD 375) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “H.C. Wainwright & Co., LLC received the above sales commission and the HCW Warrants in connection with the private placement and a concurrent registered direct offering by the Issuer, which is not reported on this Form D.”
  • On the amounts: “"Includes warrants to purchase (i) up to 2,261,538 shares of common stock issued to certain institutional investors and (ii) up to 135,692 shares of common stock issued to H.C. Wainwright & Co., LLC (""HCW Warrants""), and all underlying shares thereof."”

Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 5, 2018. Read the notice at the SEC.

optionsSEC
May 2012$1 MNo. 1Under $2 million

Bio-Path Holdings Inc.: Raise no. 1, May 2012

Investors in this round

62 investors had bought by the notice of Nov 1, 2012: 62 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $4 M offered; $3 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$400,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Utah

People named in the notice

  • Douglas P. Morris · Executive Officer, Director, Promoter
  • Peter H. Nielsen · Executive Officer, Director
  • Gillian P. Ivers-Read · Director
  • Michael J. Garrison · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • ACAP FINANCIAL (CRD 07731) · Salt Lake City, UtahSold in AZ, CA, ID, UT

Remarks in the notice

  • On fees: “Plus one share for every ten shares sold.”

Signed by Douglas P. Morris, Vice President. Source: SEC Form D, newest notice filed Nov 1, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Bio-Path Holdings Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2024).

    SEC Form D · Oct 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2024

That is all the official record says: Bio-Path Holdings Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Bio-Path Holdings Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 62 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Bio-Path Holdings Inc.
NameRoleNamed in
Peter H. NielsenExecutive officerOct 2024
Douglas P. MorrisExecutive officerNov 2012
Aline P, SherwoodDirectorOct 2024
Douglas P, MorrisDirectorOct 2024
Heath W. CleaverDirectorOct 2024
Paul D. AubertDirectorOct 2024
Peter H. NielsenDirectorOct 2024
Aline P. SherwoodDirectorJun 2024
Douglas P. MorrisDirectorJun 2024
Aline D. SherwoodDirectorNov 2022
Mark P. ColonneseDirectorMar 2019
Gillian P. Ivers-ReadDirectorNov 2012
Michael J. GarrisonDirectorNov 2012
Douglas P. MorrisPromoterNov 2012